Does TAZEMETOSTAT HYDROBROMIDE Cause Disease progression? 267 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 267 reports of Disease progression have been filed in association with TAZEMETOSTAT HYDROBROMIDE (TAZVERIK). This represents 20.2% of all adverse event reports for TAZEMETOSTAT HYDROBROMIDE.
267
Reports of Disease progression with TAZEMETOSTAT HYDROBROMIDE
20.2%
of all TAZEMETOSTAT HYDROBROMIDE reports
44
Deaths
44
Hospitalizations
How Dangerous Is Disease progression From TAZEMETOSTAT HYDROBROMIDE?
Of the 267 reports, 44 (16.5%) resulted in death, 44 (16.5%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZEMETOSTAT HYDROBROMIDE. However, 267 reports have been filed with the FAERS database.
What Other Side Effects Does TAZEMETOSTAT HYDROBROMIDE Cause?
Off label use (298)
Fatigue (292)
Nausea (207)
Product dose omission issue (183)
Death (106)
Diarrhoea (100)
Decreased appetite (81)
Asthenia (75)
Vomiting (75)
Constipation (66)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TAZEMETOSTAT HYDROBROMIDE Alternatives Have Lower Disease progression Risk?
TAZEMETOSTAT HYDROBROMIDE vs TAZOBACTAM
TAZEMETOSTAT HYDROBROMIDE vs TBO-FILGRASTIM
TAZEMETOSTAT HYDROBROMIDE vs TEBENTAFUSP-TEBN
TAZEMETOSTAT HYDROBROMIDE vs TECFIDERA
TAZEMETOSTAT HYDROBROMIDE vs TECHNETIUM TC-99M